Proton pump inhibitors impact on post-endoscopic retrograde cholangiopancreatography pancreatitis

Pancreas

Volumn 44, Issue 4, 2015, Pages 680-681

  Abdelfatah, Mohamed M ^a   Nayfe, Rabih ^a   El Zoghbi, Maysaa ^b   Gallegos, Patrick ^c   Shill, Martin ^a   Kandil, Hossam ^d  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ACUTE PANCREATITIS; ADULT; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; ACUTE DISEASE; ADOLESCENT; ADVERSE EFFECTS; AGED; CASE CONTROL STUDY; EVALUATION STUDY; PANCREATITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928468006     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000302     Document Type: Letter

References (11)

1. ASGE Standards of Practice Committee, Anderson MA, Fisher L, et al. Complications of ERCP. Gastrointest Endosc. 2012; 75:467-473.
2. Simon WA, Sturm E, Hartmann HJ, et al. Hydroxyl radical scavenging reactivity of proton pump inhibitors. Biochem Pharmacol. 2006;71:1337-1341.
3. Hackert T, Tudor S, Felix K, et al. Effects of pantoprazole in experimental acute pancreatitis. Life Sci. 2010;87:551-557.
4. Kukor Z, Mayerle J, Kruger B, et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem. 2002;277:21389-21396.
5. Niederau C, Grendell JH. Intracellular vacuoles in experimental acute pancreatitis in rats and mice are an acidified compartment. J Clin Invest. 1988;81:229-236.
6. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000;95: 2795-2800.
7. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42: 503-515.
8. Guillaumes S, Blanco I, Villanueva A, et al. Chloroquine stabilizes pancreatic lysosomes and improves survival of mice with diet-induced acute pancreatitis. Pancreas. 1997; 14:262-266.
9. Handa O, Yoshida N, Fujita N, et al. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006;55:476-480.
10. Das S, Ganguly A, Ghosh A, et al. Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. Ther Drug Monit. 2012;34: 242-244.
11. Sundstrom A, Blomgren K, Alfredsson L, et al. Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis-results from a Swedish Case-Control Study. Pharmacoepidemiol Drug Saf. 2006;15:141-149.